These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells. Savai R; Schermuly RT; Pullamsetti SS; Schneider M; Greschus S; Ghofrani HA; Traupe H; Grimminger F; Banat GA Cancer Res; 2007 Jun; 67(11):5443-53. PubMed ID: 17545626 [TBL] [Abstract][Full Text] [Related]
26. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy. Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874 [TBL] [Abstract][Full Text] [Related]
28. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Tacken PJ; de Vries IJ; Torensma R; Figdor CG Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902 [TBL] [Abstract][Full Text] [Related]
29. Mucin-1 is expressed on dendritic cells, both in vitro and in vivo. Cloosen S; Thio M; Vanclée A; van Leeuwen EB; Senden-Gijsbers BL; Oving EB; Germeraad WT; Bos GM Int Immunol; 2004 Nov; 16(11):1561-71. PubMed ID: 15381671 [TBL] [Abstract][Full Text] [Related]
30. Tumor-dendritic cell fusion technology and immunotherapy strategies. Shu S; Cohen P J Immunother; 2001; 24(2):99-100. PubMed ID: 11265778 [No Abstract] [Full Text] [Related]
31. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T lymphocyte priming versus cytotoxic T lymphocyte tolerance induction: a delicate balancing act involving dendritic cells. Melief CJ; Schoenberger S; Toes R; Offringa R Haematologica; 1999 Jun; 84 Suppl EHA-4():26-7. PubMed ID: 10907460 [No Abstract] [Full Text] [Related]
33. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells. Van Meirvenne S; Dullaers M; Heirman C; Straetman L; Michiels A; Thielemans K Mol Ther; 2005 Nov; 12(5):922-32. PubMed ID: 16257383 [TBL] [Abstract][Full Text] [Related]
34. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique. Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268 [TBL] [Abstract][Full Text] [Related]
35. [Immunogenic reactivity of CTLs induced by electrofusion cells of human dendritic cells and gastric cancer cells]. Imura K; Hayashi T; Yano Y; Naito K; Kouhara J; Ueda Y; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H Gan To Kagaku Ryoho; 2004 Oct; 31(11):1797-9. PubMed ID: 15553719 [TBL] [Abstract][Full Text] [Related]